Kassiotis lab

Retroviral Immunology Laboratory

 Publications

Numerous retroviral particles (pseudocoloured) endogenously produced by lymphoma cells in an immune-deficient mouse.

Publications

Year published

Research topics

Publication type

Journal

Displaying 1 - 20 of 27
Last updated : 19 April 2024 03:06

Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign

Authors (22)
The Lancet
Published
Crick labs/ facilities
Full details

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Authors (36)
Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Authors (67)
Cancer Cell
Published
Crick labs/ facilities
Full details

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Authors (64)
Cell Reports Medicine
Published
Crick labs/ facilities
Full details

SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies

Authors (21)
Science Translational Medicine
Published
Crick labs/ facilities
Full details

Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer

Authors (62)
The Lancet
Published
Crick labs/ facilities
Full details

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

Authors (19)
The Lancet
Published
Crick labs/ facilities
Full details

Three-dose vaccination elicits neutralising antibodies against omicron

Authors (26)
The Lancet
Published
Crick labs/ facilities
Full details

Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer

Authors (65)
Cancer Cell
Published
Crick labs/ facilities
Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)
Nature Cancer
Published
Crick labs/ facilities
Full details

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Authors (98)
Nature Cancer
Published
Crick labs/ facilities
Full details

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Authors (89)
Nature Cancer
Published
Crick labs/ facilities
Full details

Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients

Authors (86)
The Lancet
Published
Crick labs/ facilities
Full details

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains

Authors (30)
eLife
Published
Crick labs/ facilities
Full details

AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC

Authors (24)
Lancet
Published
Crick labs/ facilities
Full details

E3 ubiquitin ligase HECTD2 mediates melanoma progression and immune evasion

Authors (15)
Oncogene
Published
Crick labs/ facilities
Full details